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Biofilms have negative and positive impacts depending on the context they develop. They can 
cause acute diseases or aid in the treatment of hazardous contaminants in the environment. 
Biofilm formation is coordinated by quorum sensing using signaling factors molecules 
synthesized by bacteria.  In previous studies, small molecules were identified from biological 
sources such as mixed microbial cultures from wheatgrass and an ant mound-derived microbial 
culture where bacteria communicate. In this work, I optimized a biofilm assay to evaluate the 
effect of eleven indole derivatives, twelve 2,5-Diketopiperazines, namely, four diastereomers of 
cyclo-Phenylalanine-Proline, cyclo-Leucine-Proline, and cyclo-Valine-Proline and two 12-
hydroxystearic on the biofilm formation of E. coli. I found that among the compounds tested 
three indole derivatives 5-bromoindole, 5-chloroindole, and methyl indole 6- carboxylate, and 
two 12-hydroxystearic acid, showed inhibition of biofilm formation in a dose-dependent manner. 
And that the effect of the 2,5-Diketopiperazines was subtle however indicate the relevance of 
stereochemistry in its biological activity. This data suggest that the screening of new molecules 
isolated from different bacterial environments are key to decipher how bacteria interact with 
each other. 
 
1. Introduction  
 
1.1 Biofilm: a brief introduction  
 
Biofilms are collectives of microorganisms attached to a surface through a self-produced 
extracellular matrix whose composition depends on bacterial species and environmental 
conditions. The extracellular matrix primarily contains exopolysaccharides (EPS), DNA, lipids, 
proteins, and other polymeric compounds. Water, nutrients, air, and waste are exchanged 
through the porous present in the biofilm structure1. Biofilm formation is coordinated by a cell-
cell communication mechanism called quorum sensing (QS). It relies on the synthesis and 
secretion of signaling molecules. Both Gram-positive and Gram-negative bacteria exploit this 
mechanism. Gram-positives use oligopeptides while Gram-negatives respond to acyl-homoserine 
lactones (AHLs)2. Biofilm formation can be defined in the following steps: attachment, 
maturation, and dispersion. During attachment, bacteria in close contact with a surface use 
adhesive structures such as fimbriae, pili, and flagella to interact with the surface and establishing 
microcolonies. Maturation initiates with the production of the exopolysaccharide matrix 
regulated by QS. Upon the irreversible link of the initial cells to the surface, more cells adhere, 
forming complex structures. After maturation, biofilms disperse, the dissociation of planktonic 
cells induces the spreading of biofilm to new locations3–6. The extracellular matrix serves as a 
protective mechanism under unfavorable conditions making bacteria immersed in biofilms more 
resistant to antibiotics and shearing forces7. The extracellular matrix reduces the penetrability of 
antibiotics and increases the probability of horizontal gene transfer of antibiotics resistant genes. 
Extracellular DNA was found to prevent the diffusion of vancomycin protecting bacteria inside 
the biofilm8. Savage et al. observed that biofilms bring bacteria in intimate contact, providing the 
conditions for horizontal gene transfer facilitating antibiotic-resistant genes exchange 9.  
 
1.2 Negative and positive aspects associated with Biofilms 
 
Virtually all kinds of surfaces can be colonized by bacteria and be the target of attachment 
and biofilm formation. Due to the ubiquitous presence and highly resistant nature of biofilms, 
they are responsible for chronic and nosocomial infections10, food spoilage, contamination in the 
food industry facilities11, and industrial pipes and ship fouling12. 
Medical devices such as pacemakers, catheters, contact lenses are suitable surfaces for 
bacterial attachment and formation of biofilm13–15. They also cause persistent infections and 
diseases such as cystic fibrosis, chronic wounds, urinary tract infections, and chronic 
osteomyelitis16.  It is believed that over 65% of infections are caused by biofilm-related bacteria.  
Biofilms also present a significant threat to the food industry; bacteria can establish them on 
many materials rubber, glass, wood, polypropylene, polyethylene, stainless steel, and food 
products. About 60% of foodborne infections are due to biofilms; toxins can be secreted and 
contaminate a food facility; toxins can cause diarrhea, emetic syndrome, among other types of 
intoxications17. In addition, biofilms also affect the food product itself, altering the organoleptic 
properties as a result of food spoilage18.  
Another severe issue generated by biofilms is biofouling; biological fouling is the 
aggregation of microorganisms, algae, and small animals on a surface in contact with water.  This 
presents a huge challenge for the civil and industrial naval industry along with underwater pipe 
systems. Biofouling is developed through the successive attachment of different organisms 
where biofilm-forming bacteria are the first colonizers. In a naval setting, biofouling increases the 
surface roughness resulting in frictional resistance that reduces speed and increases fuel 
consumption. Measures to prevent biofilm on ships and industrial pipes are the use of coatings; 
however, most of these coats are toxic to the marine environment and have been banned19,20. 
New environmentally friendly molecules are required on coatings to prevent biofouling 
development, and the trend points to the blockage of adherence of the first settler’s biofilm-
forming bacteria. 
Despite their adverse effects, biofilms provide a valuable resource when applied in 
different industrial settings such as bioremediation21, wastewater treatment22 , plant 
protection23 among other applications. Bioremediation provide a complete biodegradation of 
hazardous substances to its molecular constituents24. Biofilms present an advantageous form of 
bacterial growth for bioremediation processes due to the high tolerance of bacterial to harsh 
conditions and the potency of their biochemical enzymatic machinery. Bioremediation has 
proved to be more efficient than conventional chemical treatments regarding cost and 
environmental safety21. Another process that take advantage of biofilm forming bacteria is 
wastewater treatment using them to degrade organic and inorganic compounds, digesting excess 
of nutrients and even exploiting the energy conserved in organic molecules25. As the new 
technology bioelectrochemical systems (BESs) does using biofilms to catalyze the bioconversion 
of organic waste into electrical energy through oxidation-reduction reactions26. In addition, 
biofilms also protect plants against pathogens via symbiotic relations. Since biofilms can be 
formed in leaves, roots, and stems, they can overgrowth pathogens and produce antagonistic 
metabolites that prevent the colonization of harmful bacteria27. As presented above, Biofilms 
have negative and positive impacts based on the environment they develop.  
 
1.3 New signaling factors from mixed cultures 
  
Microorganisms communicate using signaling factors (SF) which are molecules 
synthesized and secreted by bacteria and modulate different bacterial processes. Bacteria scan 
and access the molecular information in their environment by sensing signaling factors that are 
transported out of the cells28–30. The concentration of these compounds becomes significant 
when the cell density increases. At a certain concentration threshold, the molecule triggers a 
signaling cascade, leading to the induction of a change in the bacterial phenotype2. The best 
studied signaling factors are Autoinducer-2, acyl-homoserine lactones, several diketopiperazines, 
and various peptides31. The study of signaling factors is challenging due to axenic cultures which 
do not recreate the bacterial native environment where they communicate to the intra- and 
inter-species levels. Previous studies in the lab demonstrated the stability of a mixed microbial 
culture (MMC) derived from wheatgrass and their valuable use in the investigation of microbial 
communication32. During the study of wheatgrass MMC, a potential new interspecies signaling 
factor was isolated; it is a mixture of two stereoisomers of 12-hydroxystearic acid (12-HSA), in 
which  (R)-12-HSA is the predominant (~90%) stereoisomer. In this same study the effects of 
commercial 12-HSA on marine bacterial strains were tested, and the results showed that 12-HSA 
modulated biofilm formation and planktonic cell growth in a strain-dependent manner. The work 
demonstrated that MMCs can serve as a simple yet powerful platform to discover previously 
overlooked signaling factors for microbial communication.  
 
1.4 Indole and indole derivatives modulate the formation of biofilm 
 
  Indole is a key bacterial signal molecule that regulates critical biological processes such as 
genetic stability, biofilm formation, pathogenesis, and antibiotic resistance. Indole is produced 
by both Gram-positive and Gram-negative bacteria33. Over 85 species of bacteria have been 
documented to be able synthesize Indole. However, producers and non-producers have been 
reported to respond to exogenous Indole changing their behavior34. It also acts as an interspecies 
and interkingdom signal to regulate diverse functions 35,36. For example, Indole regulates biofilm 
formation in E. coli, inhibiting it in a non-toxic manner while it induces the formation of biofilm 
in V. cholerae and in Pseudomonas aeruginosa 33,37. Indole is subject to oxidation by oxygenase 
produced by many bacteria, and oxidation generates indole derivatives with comparable effects 
to indole itself on biofilm formation34,38,39. Several indole derivatives have shown inhibition of 
biofilm formation on different bacterial species. For example, 5-Iodoindole showed biofilm 
inhibition of different strains of Acinetobacter baumannii40, 3-Indolylacetonitrile inhibits  
Escherichia coli O157:H7 Biofilm Formation38. 3-indoleacetonitrile, 5-fluoroindole, 6-
fluoroindole, 7-fluoroindole, 7-methylindole, 7-nitroindole, 5-iodoindole, 5-fluoro-2- 
methylindole, 2-methylindole-3-carboxaldehyde, and 5-methylindole inhibit biofilm formation 
interfering with quorum sensing41. This suggest that indole derivatives are a source of biofilm 
inhibitors that should be exploited.  
 
 
1.5 Effect of Diketopiperazines in biofilm formation  
 
2,5-Diketopiperazines (DKPs) are cyclic dipeptides ubiquitously found in mammals, plants, 
fungi, and bacteria42. DKPs are synthesized as functional secondary metabolites by non-ribosomal 
peptide synthetases (NRPS) or as side products of protein metabolism43,44.  DKPs have shown a 
wide variety of biological activities depicting antimicrobial45, anticancer46, and anti-
inflammatory47 properties. It has been well documented that some DKPs are considered signaling 
factors in cell-cell communication because they are capable of activating and inhibiting LuxR-
based QS system18,28,48. For example, Zhu et al. demonstrated the positive role of cyclo(L-Pro-L-
Phe) DKPs in biofilm formation, increasing its formation in Shewanella putrefaciens and 
Shewanella baltica48 . Park et at. Demonstrated that cyclo(L-Phe-L-Pro) is a signal molecule that 
controls the expression of genes involved in the pathogenicity of Vibrio spp.  Consequently, DKPs 
can be described as naturally occurring QS signals which can act intra and inter species.  
Several studies indicate that the stereochemistry DKPs is important for biological effects. 
For example, five identified DKPs showed strong antibiotic activity against Vibrio anguillarum. 
cyclo(D-Phe-D-Pro), cyclo(D-Leu-D-Pro), cyclo(D-Pro-D-Val), cyclo(D-Ile-D-Pro), and cyclo(D-Phe-
trans-4-OH-D-Pro)42. However, structure activity studies and comparations with other 
stereoisomers containing L-amino acids revealed that at least one D-amino acid was required for 
the antibacterial activity and in general D,D-enantiomers performed better. DKPs such as 
cyclo(Phe- Pro), cyclo(Leu-Pro), and cyclo(Val-Pro) are often found in bacterial cultures acting as 
a agonist or antagonist of QS systems in biofilm formation28,29,49–51. Each of these DKPs has four 
possible stereoisomers due to the presence of two chirality centers. Although biological activity 
of DKPs have been well documented, comparing the stereochemistry of 2,5-Diketopiperazines 
reported in the literature does not produce a clear answer for the effect of the stereoisomers in 
their biological activity. The study of the effect of the four stereoisomers of cyclo(Phe- Pro), 
cyclo(Leu-Pro), and cyclo(Val-Pro) on biofilm formation has not been analyzed yet and this 
information is critical since stereochemistry is a key determinant of biological activity.  
 
1.6 Measuring biofilm formation 
 
There are several methods to study biofilm formation produced by bacteria. However, 
static biofilm systems are preferred over chemostat to study early stages of biofilm formation. 
These types of assays can be conducted using common laboratory equipment. Crystal Violet (CV) 
biofilm assay is a critical tool that allows the quantification of biofilm based on crystal violet 
staining, which stains both living and dead cells. It was originally described by Christensen et al52. 
in 1985 and it has been used since then to study biofilms in the laboratory. Crystal Violet biofilm 
assay performed on microtiter plates permit the formation of biofilm in the walls and the bottom 
of the wells, CV bound to the biofilm is solubilized and offers a quantitative analysis. Modification 
of this assay has been used with Gram-positive and Gram-negative bacteria. Static crystal violet 
microtiters assay has facilitated the screening of different compounds for their effect on biofilm 
formation and disruption. 53–59. It was used to measure the effect of Iodoindoles on biofilm 
formed by Acitenobacter baumanii40. And to measure the effect of DKPs cyclo-(L-Pro-L-Phe) on 
biofilm formation by Shewanella baltica48.  Overall, this method is relatively easy, inexpensive 
and it can be performed routinely.   
In this Thesis I aimed at optimizing a microtiter Crystal Violet assay with the purpose of 
having an in-house biofilm assay to i) study the effect of stereoisomeric mixtures of 12-HSA on 
biofilm formation, ii) test the effect of indole derivatives on biofilm formation, and iii) explore 
the effect of stereochemistry of different 2,5 Diketopiperazines on biofilm formation. The 
ultimate goal of this research program is to use chemical factors that aid in the suppression of 
problematic biofilms and the promotion of beneficial biofilms.   
2. Methods  
 
2.1 Bacterial Strains and Chemicals  
 
Escherichia. coli BL21 (DE3) (kind gift of Dr. Yujia Xu),  Bacillus subtilis 
1681A1(ATCC)  Media Luria-Bertani (LB) (MP Biomedicals, Fisher scientific), Reasoner's 2A (R2A) 
(MP Biomedicals, Fisher scientific), Crystal Violet (CV)(Fisher scientific), Glacial Acetic Acid (Fisher 
scientific), 96-well polypropylene plates (VWR), 6-Chloroindole, 5-Chloroindole, 6- Methylindole, 
6-Nitroindole, 5-Methoxylindole, 5-CyanoIndole, 5-BromoIndole, Indole-3-Carboxaldehyde, 6-
Methoxyindole, Methyl Indole 6-Carboxylate. (Fisher scientific). Twelve 2,5-Diketopiperazines, 
namely, cyclo(L-Phe-D-Pro), cyclo(D-Phe-L-Pro), cyclo(L-Phe-L-Pro) , cyclo(D-Phe-D-Pro), cyclo(L-
Leu-D-Pro), cyclo(L-Leu-L-Pro), cyclo(D-Leu-L-Pro), cyclo(D-Leu-D-Pro), cyclo(L-Val-D-Pro), 
cyclo(L-Val-L-Pro), cyclo(D-Val-L-Pro), and cyclo(D-Val-D-Pro), were synthesized by the Ph.D. 
candidate Alison Domzalski and Undergraduate students Sharifa Kamga, Ezoza Yunusova, 
Katherine Gee, and Angelica Foronda, via a facile microwave-assisted approach60. The 
synthesized library was subjected to spectroscopic characterization using mass spectrometry, 
NMR, and electronic circular dichroism (ECD) was used to differentiate all four the stereoisomers 
of each DKP. 12-Hydroxystearic acid (R-isomer) (Fisher scientific), racemic 12-Hydroxystearic acid 
was prepared by Dr. Kawamura with the help of undergraduate students Kazi Muztabir, Valentina 
Volpe, and Masuda Begum. Dimethyl sulfoxide (DMSO) (Fisher chemicals), which did not exceed 
1% (v/v) in any experiment. DMSO was also used as a negative control in all experiments at a 
concentration in media of ≤ 1% (v/v); it did not affect cell growth.  
 
2.2 Bacterial Strains and Growth Conditions 
 
 E. coli BL21 (DE3) was used as the primary candidate for protocol optimization followed 
by Bacillus subtilis as Gram-negative and Gram-positive model bacteria respectively. These 
bacteria were selected due to its availability, non-pathogenicity and known biofilm formation 
capacity. Two media were evaluated Luria-Bertani (LB) and R2A broth made according to the 
manufacture specification. Bacterial cultures of E.coli were growth by inoculating 20ml of LB with 
one loop of the frozen stock and incubated overnight at 37°C and 200rpm agitation. B.subtilis 
was growth on LB media and incubated overnight at 30°C with 200rpm agitation.  
 
2.3 Optimization of a microtiter biofilm assay with E. coli and B.subtilis 
 
A static biofilm formation assay as described previously4 was optimized with minor 
modifications. The following parameters were optimized:  
• Inoculum size: starting inoculum size was evaluated by diluting an overnight 
culture of the respective strain in different cell concentrations and assessing biofilm 
formation.  
• Incubation time: assay incubation time was evaluated at two ending points 24 and 
48 hr and 72hrs. 
• Media: two media were evaluated Luria-Bertani (LB) Broth and Reasoner's 2A  
(R2A).  
 
2.4 Characterization of Biofilm Formation  
 
The capacity of E. coli BL21 (DE3) and B. subtilis to form biofilm on 96-well polystyrene 
microtiter flat-bottom plates was evaluated with the following protocol. Briefly, overnight 
bacterial culture was diluted to OD600: 0.15 - 0.2 ~ 1.2 x 108 cells/ml. 200µl of the cell dilution 
was added to 96-well polystyrene microtiter plates in at least four wells and incubated at the 
optimized temperature 37°C for E. coli or 30°C for B. subtilis for 24 and 72 hr. respectively with 
no agitation. After the incubation time, planktonic cells were removed by carefully flipping over 
the plate. The wells were rinsed with deionized water two times, and then biofilms were fixed 
with heat for 30 min at 60 ºC. 200µl of 0.2% (wt./vol) Crystal Violet (CV) solution in water was 
added to the wells and incubated for 15min at room temperature, then the excess of CV was 
removed, and the wells were rinsed with deionized water two times. Plates were air-dried for 
one hour at room temperature, and the stained biofilm was resuspended in 33% (vol/vol) glacial 
acetic acid solution then transferred to a new plate. Biofilm formation was quantified by 
measuring Crystal Violet's absorbance at 595nm in a Microplate Reader (Molecular Devices 





2.5 Biofilm inhibition assay 
 
The inhibition of biofilm formation was assessed by the method as described 
previously54,60 with minor modifications. Indole was used as a positive control. The inoculum was 
prepared by dilution as described above. 200µl of this dilution was added to each well on a 96-
well polystyrene microtiter plate, avoiding the edges. 2 µl of the small molecules to be tested 
were added to each well 1% DMSO was used as a negative control of inhibition and 2 µl of Indole 
as a positive control. Plates were incubated at the optimal conditions for each strain without 
agitation. After the incubation time, the planktonic cells were removed, and the wells were rinsed 
with deionized water two times. The biofilms were heat-fixed at 60°C for 30 min. Biofilm was 
stained with CV and quantified as described previously. The experiment was repeated three 
times independently with at least four replicates. 
 
2.6 Evaluation of Cell Viability in Biofilms 
 
The planktonic cells growth can give information about the toxicity of the compounds 
being tested and their mechanism of action. Biofilm might be inhibited through the disruption of 
planktonic cells growth. Cell viability in the biofilm was performed only on the compounds that 
depicted high inhibition of biofilm to uncover toxic effects. Cell viability was performed by plate 
spotting by the method described previously55. After 24hr of incubation with the samples, 100 µl 
of planktonic cells were transferred to a new 96-well plate, and the wells were washed two times 
with deionized water. Next, 200µl of LB media was added to the wells; cells were detached by 
pipetting vigorously, followed by 10-fold serial dilutions of the cell suspension were made in LB 
media and spotted on nutrient media agar and incubated for 24hrs at 37°C and 30°C depending 
on the strain.   
2.7 Statistical Analysis  
 
Each experiment was performed at least twice in triplicate. t-test was used 
to calculate the difference between replicates to determine significance between samples and 
the controls. P values of < 0.05 were regarded as significant. 
3. Results  
 
 
3.1 Effect of media, inoculum size and incubation time on biofilm formation 
 
The effect of two different media was evaluated on the biofilm formation of E. coli. LB 
and R2A media were used to prepare serial dilutions from a fresh overnight culture of E. coli. 
Biofilm formation was evaluated at different inoculum sizes Fig.1 as well as two incubation times 
Fig.A1. Overall, E. coli exhibited CV staining in all the cell dilutions. However, biofilm formed in LB 
Fig.1b showed less variability in the values of the absorbance of CV, while CV absorbance values 
Figure 1. Effect of inoculum size and medias R2A and LB on E. coli BL21 (DE3) biofilm formation in a crystal violet 
microtiter assay. 
of biofilm formed on R2A were more dispersed. In general, the effect of inoculum size did not 
affect biofilm formation considerably. All cell dilutions on LB showed that E. coli formed biofilm 
consistently at all inoculum concentrations. In the end, 1:10 dilution of the overnight culture was 
selected as the starting inoculum concentration for our assays because this inoculum size reduces 
the lag phase and aid in the shifting from planktonic state to sessile state. E. coli produced a 
mature and consistent biofilm at 24 hours, and all the E. coli assays were conducted in 24 hours. 
Optimization of the biofilm assay with B. subtilis was conducted by assessing two medias 
R2A and LB, three time points 24, 48, and 72 hrs and different inoculum sizes. The resulting 
optimal parameters for the assay with B. subtilis were: LB media was selected due to CV staining 
reached higher values than with R2A. B. subtilis formed a less robust biofilm compared to E. coli, 
and it required a longer time of development. At 72 hrs. of incubation, the data was more 
consistent and less disperse. The inoculum size selected for the optimization of the positive 
control was OD600 ~0.1-0.2. Indole was tested for inhibition of biofilm formation of B.subtilis Fig. 
A3 and due to its dose-dependent inhibition it was used as a positive control in the biofilm assay. 
Although the microtiter biofilm assay with B. subtilis was optimized in Spring 2021, we have not 
had a chance to use it for compound screening yet. As such, the subsequent sections will focus 











Figure 2. Chemical structure of Indole derivatives. 
 
Figure 2. Effect of Indole derivatives with the highest antibiofilm activity. 11 indole derivatives were screened for inhibition of biofilm 
formation by E. coli. 
3.2 Indole derivatives inhibit biofilm formation 
 
Indole is an organic compound involved in bacterial communication and it is responsible 
for the coordination of different bacterial responses to the environment through quorum sensing 
including biofilm formation as a protective mechanism33. Due to the relevance and biological 
activity of indole, eleven indole derivatives were screened for their effect on E. coli BL21 (DE3) 
biofilm formation Fig. 2. Commercially available indole derivatives were resuspended in DMSO 
and dosed initially at 0.1 mg/ml using indole as a control at 1.2mg/ml for inhibition and DMSO as 
vehicle control, indole dimer was tested a 0.01mg/ml due to the limited availability of the sample. 
Initial screening showed that 5-chloroindole, 5-bromoindole, and methyl indole 6-carboxylate 
consistenly reduced significantly E. coli biofilm formation where the other indole derivatives 
tested had less or no sustained effect on biofilm formation Fig. A4. 5-cromoindole, 5-chloroindole 
and methyl indole 6- carboxylate at 0.1mg/ml inhibited biofilm formation of E. coli BL21 (DE3) by 
74, 70 and 61% respectively. In addition, at higher concentration 0.2 mg/ml significantly and in a 
dose-dependent manner all the three derivatives 5-bromoindole, 5-chloroindole and methyl 
indole 6- carboxylate inhibited biofilm formation of E. coli BL21 (DE3) Fig. 4A, 4C, 4E. Both 5-
bromoindole and 5-chloroindole inhibited planktonic cell growth at 0.1 mg/ml Fig. 4B,4D. 
However, at this same concentration methyl indole 6- carboxylate slightly inhibited the 
planktonic cell growth since bacterial spotting at 0.1mg/ml showed similar viable cells as the 
DMSO control Fig. 4F. In addition, the planktonic cell growth at the end point of the experiment 
Fig. A5 also showed slight inhibition of planktonic cells. This data sugests that the mechanism of 
biofilm inhibition of 5-bromoindole and 5-chloroindole is throught their toxic effect on planktonic 
cells growth, whereas methyl indole 6- carboxylate could be a potential signaling factor since its  
 
Figure 3. Effect of 5-bromoindole, 5-chloroindole and methyl indole 6-carboxylate on E. coli biofilm formation and cell growth. 









































































































































































































Figure 4. Synthetic 2,5 Diketopiperazines library. 
Figure 5. Effect of the four possible stereoisomers of the 2,5 Diketopiperazines (A)cyclo(Phe-Pro), (B) cyclo(Leu-Pro), 
and(C) cyclo(Val-Pro) on E. coli biofilm formation. 
A B C 
3.3 2,5-Diketopiperazines modulate E. coli biofilm formation  
 
2,5-Diketopiperazine are cyclopeptides produced by gram-positive and gram-negative 
bacteria. Previous studies have shown that 2,5-Diketopiperazines have a positive effect on 
quorum sensing and stimulate biofilm formation in different bacterial species48. A previous study 
in the laboratory performed by the Ph.D candidate Alison Domzalski identified and isolated a 2,5-
Diketopiperazine cyclo(Phe-Pro) from an ant derived mixed microbial culture. In this study Alison 
Domzalski built a synthetic library of cyclo(Phe-Pro), cyclo(Leu-Pro), and cyclo(Val-Pro) due to 
they were detected in the mixed bacterial culture. With the goal to achieve a complete 
characterization of their stereochemistry in relation with their biological activity in this case 
biofilm formation specifically on E. coli BL21. In this research work I screened a library composed 
of a total of twelve 2,5-Diketopiperazines, namely, four diastereomers of cyclo-Phenylalanine-
Proline, cyclo-Leucine-Proline, and cyclo-Valine-Proline Fig. 5 for their effect on the biofilm 
formation of E. coli. Initially, DKPs were screened at 0.1 mg/ml concentration Fig. S5. The 
screening showed not dramatic effect of the three DKPs on the biofilm formation of E. coli. 
However, Cyclo-Phe-Pro having at least one amino acid with D conformation (L-Phe-D-Pro, D-
Phe-L-Pro, and D-Phe-D-Pro) produced a slight increase in biofilm formation Fig. 6A. In 
comparison, L-Phe-L-Pro did not have a significant effect on biofilm formation by E. coli. Fig. 6C. 
Also shows that cyclo (Val-Pro) produces some inhibition of biofilm formation in the presence of 
D-Proline. This data suggests that the stereochemistry conformation of the DKPs have some 
effect on biofilm formation of E. coli. But it is not significative enough to confirm the hypothesis 
that the stereochemistry plays a role in biofilm formation at least on E. coli.  Further investigation 
such a dose response test of the cyclo(L-Val-D-Pro) and cyclo(L-Val-L-pro) is required to confirm 
its effect, and perhaps other bacterial species could show a more dramatic response to the effect 







Figure 6. Effect of commercial racemic 12-hydroxystearic acid (12-HSA) and 12-hydroxystearic acid (R-isomer) on E. 
coli’s biofilm formation and planktonic cell growth. (A) and (B) Biofilm biomass and planktonic cell growth of E. coli 
treated with different concentration of racemic 12-HSA. (C) and (D) Biofilm biomass and planktonic cell growth of E. 
coli treated with different concentration of R-isomer of 12-HAS. Measured with Crystal Violet biofilm assay and OD600 
in a Microplate Reader (Molecular Dev.) 
3.4 Racemic 12-Hidroxystearic acid modulates biofilm formation of E. coli  
 
To evaluate the effect of the stereochemistry of 12- HSA on the biofilm formation of E. 
coli BL21.  Commercial 12-HSA (R-isomer) and a racemic mixture of (R) and (S)-stereoisomers of 
12-HSA were tested at different concentration 200-25µg/ml Fig. 7. The data shows modulation 
of biofilm formation where at the highest concentration tested 200 µg/ml, inhibition of biofilm 
is evident and at lowest concentration 25 µg/ml there is a slight increase of biofilm. The presence 
of S-isomer in the racemic 12-HSA has a more significant impact on biofilm inhibition, reaching 
~48%. In contrast, the R-isomer inhibition was ~29% compared to the DMSO control. This effect 
is also noticed in the promotion of biofilm, whereas racemic 12-HSA increased biofilm biomass 
in ~18% while 12-HSA (R-isomer) increased biofilm biomass in ~15%. The planktonic growth was 
not affected.  Instead, a subtle increase can be observed for both compounds. This data corelate 
with the effect of commercial 12-HSA previously tested on marine bacteria32 . The data presented 
suggest that 12-HAS isolated from mixed bacterial cultures is an inter species signaling factor that 
modulates biofilm formation without affecting planktonic growth.  
4. Conclusion  
 
Biofilms have negative and positive impacts depending on the context they develop. To being 
able of modulating biofilm formation, exploration on how microbial communities communicate 
and coordinate biofilm formation is urgently required. The screening of new molecules isolated 
from bacterial environments are key to decipher how bacteria interact with each other. In this 
work I tested several molecules with potential antibiofilm activity. Three indole derivatives 
inhibited the biofilm formation of E. coli BL21 more than 60%, two of these molecules 5-
bromoindole and 5-chlroindole have been reported previously in the literature while Methyl 
indole 6-carboxylate has not been reported as biofilm inhibitor of E. coli BL21. This work also 
showed the interspecies biofilm modulation capacity of 12-hydroxystearic acid where at low 
concentration it can promote its production and at high concentration it inhibits biofilm without 
affecting planktonic growth and that the impact is lightly deeper in the presence of 12-HSA (R-
isomer). Additionally, it was possible to test all the isomers of the different DKPs and observe 
their effect in biofilm formation.  However further investigation with different bacteria species is 
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Figure A 1.Effect of two incubation times on the biofilm formation by E. coli with LB media and 1:10 inoculum size. 
Figure A 2.Effect of Indole on E. coli biofilm formation. 













































































































































































































































































































































































































































































































































































































































































































































































































Figure A 4. Indole derivatives screening and follow up of the preliminary hits. Each column represents a replicate of the 


























































































































































































































































































































































































































































































































































































































































































































Figure A 6. Effect of 12 synthetic 2,5 Diketopiperazines cyclo(L-Phe-D-Pro), cyclo(D-Phe-L-Pro), cyclo(L-Phe-L-Pro), cyclo(D-Phe-D-Pro), 
cyclo(L-Leu-D-Pro), cyclo(L-Leu-L-Pro), cyclo(D-Leu-L-Pro), cyclo(D-Leu-D-Pro), cyclo(L-Val-D-Pro), cyclo(L-Val-L-Pro), cyclo(D-Val-L-
Pro), and cyclo(D-Val-D-Pro) on the biofilm formation of E. coli. Measured with a Crystal Violet microtiter assay. 
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